Skip to content

A randomized controlled study of low frequency electroacupuncture combined with cognitive behavioral therapy in the treatment of short-term insomnia

A randomized controlled study of low frequency electroacupuncture combined with cognitive behavioral therapy in the treatment of short-term insomnia

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052455
Enrollment
Unknown
Registered
2021-10-26
Start date
2021-10-26
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insomnia

Interventions

Treatment group:Low frequency electroacupuncture?Cognitive behavioral therapy
control group: Low frequency electroacupuncture

Sponsors

Wuxi People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for short-term insomnia of the above diseases; 2. Aged 18 to 70 years, and the gender is not limited; 3. The frequency of sleep difficulties and related daytime symptoms in the past month >= 1 time per week; 4. ISI score >= 8 points; 5. Not participating in other clinical trials within one month before participating in the trial, and did not use tranquilizers, acupuncture, Chinese herbal medicine or other treatments for insomnia; 6. Voluntarily and agree to cooperate with the treatment of this research plan, and sign the informed consent; 7. Able to cooperate with doctors to complete various tasks such as scoring.

Exclusion criteria

Exclusion criteria: 1. Patients with serious primary diseases such as heart, brain, liver, and kidney, as well as infectious diseases, acute diseases, and malignant tumors; 2. People with secondary insomnia (mainly including sleep disorders, physical diseases, mental disorders and drug use), poor sleep hygiene or sleep disorders caused by other reasons (changes in jet lag, environment, work, etc.); 3. Women who are pregnant or breastfeeding; 4. Those with serious adverse reactions such as fainting needles.

Design outcomes

Primary

MeasureTime frame
Pittsburgh sleep quality index;Insomnia severity index;Epworth Sleepiness Scale score;Comprehensive efficacy evaluation;Sleep personal beliefs and attitudes scale;

Secondary

MeasureTime frame
Number of people converted to chronic insomnia;

Countries

China

Contacts

Public ContactSu Qiuju

Wuxi People's Hospital

suqiuju_1982@126.com+86 15961817218

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026